uniQure (QURE) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart

QURE Stock Forecast

uniQure stock forecast is as follows: an average price target of $53.67 (represents a 768.45% upside from QURE’s last price of $6.18) and a rating consensus of 'Buy', based on 7 wall street analysts offering a 1-year stock forecast.

QURE Price Target

The average price target for uniQure (QURE) is $53.67 based on 1-year price targets from 7 Wall Street analysts in the past 3 months, with a price target range of $62.00 to $34.00. This represents a potential 768.45% upside from QURE's last price of $6.18.

QURE Analyst Ratings

Buy

According to 7 Wall Street analysts, uniQure's rating consensus is 'Buy'. The analyst rating breakdown for QURE stock is 0 'Strong Buy' (0.00%), 6 'Buy' (85.71%), 1 'Hold' (14.29%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

uniQure Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Nov 23, 2022	-	Goldman Sachs	$57.00	$25.38	124.59%	822.33%
Aug 08, 2022	Matthew Barcus	Chardan Capital	$60.00	$18.64	221.89%	870.87%
May 03, 2022	-	Credit Suisse	$51.00	$15.85	221.77%	725.24%
Jan 07, 2022	Yanan Zhu	Wells Fargo	$34.00	$19.50	74.36%	450.16%
Dec 16, 2021	Danielle Brill	Raymond James	$58.00	$20.24	186.56%	838.51%
Oct 28, 2021	Suji Jeong	Jefferies	$62.00	$30.65	102.28%	903.24%

Row per page

Go to

The latest uniQure stock forecast, released on Nov 23, 2022 by Goldman Sachs company, set a price target of $57.00, which represents a 124.59% increase from the stock price at the time of the forecast ($25.38), and a 822.33% increase from QURE last price ($6.18).

uniQure Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	-
Avg Price Target	-	-	-
Last Closing Price	$6.18	$6.18	$6.18
Upside/Downside	-100.00%	-100.00%	-100.00%

In the current month, the average price target of uniQure stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to uniQure's last price of $6.18. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Jul 09, 2024	Guggenheim	Buy	Buy	Hold
Mar 04, 2024	Cowen & Co.	Neutral	Neutral	Hold
Jun 22, 2023	Chardan Capital	Buy	Buy	Hold
Feb 28, 2023	Credit Suisse	Outperform	Outperform	Hold
Dec 29, 2022	H.C. Wainwright	Buy	Buy	Hold
Nov 23, 2022	Goldman Sachs	Buy	Buy	Hold
May 03, 2022	SVB Leerink	Outperform	Outperform	Hold

Row per page

Go to

uniQure's last stock rating was published by Guggenheim on Jul 09, 2024. The company gave QURE a "Buy" rating, the same as its previous rate.

uniQure Financial Forecast

uniQure Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.41M	-	$5.33M	$102.75M	$1.45M	$497.00K	$1.79M	$57.69M	$1.99M	$463.87M	$454.00K	$34.09M	$1.79M	$1.53M	$104.00K	$2.63M	$1.05M
Avg Forecast	$3.78M	$3.58M	$3.38M	$3.18M	$23.34M	$7.53M	$6.77M	$6.37M	$17.18M	$6.86M	$6.84M	$6.29M	$5.60M	$29.49M	$166.71M	$30.30M	$19.42M	$3.48M	$10.19M	$17.66M	$10.75M	$2.52M	$190.02M	$2.27M	$120.05M	$133.27M	$5.12M	$1.34M	$1.51M	$2.31M
High Forecast	$12.54M	$11.88M	$11.22M	$10.55M	$77.54M	$25.03M	$22.50M	$10.32M	$61.33M	$7.06M	$6.84M	$6.29M	$8.75M	$29.49M	$553.86M	$100.68M	$64.50M	$3.48M	$10.19M	$17.66M	$10.75M	$2.52M	$190.02M	$2.27M	$120.05M	$133.27M	$5.12M	$1.34M	$1.51M	$2.31M
Low Forecast	$491.28K	$465.26K	$439.24K	$413.22K	$3.04M	$980.28K	$881.08K	$4.10M	$952.75K	$6.65M	$6.84M	$6.29M	$1.23M	$29.49M	$21.69M	$3.94M	$2.53M	$3.48M	$10.19M	$17.66M	$10.75M	$2.52M	$190.02M	$2.27M	$120.05M	$133.27M	$5.12M	$1.34M	$1.51M	$2.31M
# Analysts	4	4	4	4	3	3	3	5	7	3	5	4	8	4	5	4	4	3	4	3	5	4	5	4	5	5	9	6	4	4
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.05%	-	0.18%	5.29%	0.42%	0.05%	0.10%	5.37%	0.79%	2.44%	0.20%	0.28%	0.01%	0.30%	0.08%	1.74%	0.45%

uniQure's average Quarter revenue forecast for Dec 23 based on 8 analysts is $5.60M, with a low forecast of $1.23M, and a high forecast of $8.75M. QURE's average Quarter revenue forecast represents a 298.09% increase compared to the company's last Quarter revenue of $1.41M (Sep 23).

uniQure EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	4	4	4	4	3	3	3	5	7	3	5	4	8	4	5	4	4	3	4	3	5	4	5	4	5	5	9	6	4	4
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	$-81.88M	-	$-69.98M	$28.69M	$-57.38M	$-56.06M	$-51.22M	$11.81M	$-32.74M	$406.43M	$-37.93M	$2.53M	$-47.98M	$-39.81M	$-25.29M	$-38.73M	$-20.93M
Avg Forecast	$-2.56M	$-2.43M	$-2.29M	$-2.15M	$-15.83M	$-5.11M	$-4.59M	$-4.32M	$-11.65M	$-4.65M	$-4.64M	$-34.48M	$-3.80M	$-20.00M	$-113.07M	$-36.88M	$-13.17M	$-2.36M	$-6.91M	$-39.45M	$-7.29M	$-1.71M	$-128.96M	$-36.64M	$-81.47M	$-90.45M	$-3.47M	$-31.61M	$-1.03M	$-1.57M
High Forecast	$-333.21K	$-315.56K	$-297.91K	$-280.26K	$-2.06M	$-664.87K	$-597.59K	$-2.78M	$-646.20K	$-4.51M	$-4.64M	$-27.59M	$-831.01K	$-20.00M	$-14.71M	$-29.51M	$-1.71M	$-2.36M	$-6.91M	$-31.56M	$-7.29M	$-1.71M	$-128.96M	$-29.31M	$-81.47M	$-90.45M	$-3.47M	$-25.29M	$-1.03M	$-1.57M
Low Forecast	$-8.51M	$-8.06M	$-7.61M	$-7.16M	$-52.59M	$-16.98M	$-15.26M	$-7.00M	$-41.60M	$-4.79M	$-4.64M	$-41.38M	$-5.94M	$-20.00M	$-375.65M	$-44.26M	$-43.75M	$-2.36M	$-6.91M	$-47.34M	$-7.29M	$-1.71M	$-128.96M	$-43.96M	$-81.47M	$-90.45M	$-3.47M	$-37.94M	$-1.03M	$-1.57M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	4.09%	-	1.90%	-2.18%	24.27%	8.11%	1.30%	-1.62%	19.17%	-3.15%	1.04%	-0.03%	0.53%	11.46%	0.80%	37.78%	13.37%

4 analysts predict QURE's average Quarter EBITDA for Mar 23 to be $-36.88M, with a high of $-29.51M and a low of $-44.26M. This is -228.56% lower than uniQure's previous annual EBITDA (Dec 22) of $28.69M.

uniQure Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	4	4	4	4	3	3	3	5	7	3	5	4	8	4	5	4	4	3	4	3	5	4	5	4	5	5	9	6	4	4
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	$-89.57M	-	$-77.23M	$6.81M	$-47.86M	$-39.06M	$-46.68M	$8.21M	$-36.53M	$399.47M	$-41.56M	$-699.00K	$-53.77M	$-42.55M	$-28.00M	$-41.43M	$-23.60M
Avg Forecast	$-37.84M	$-36.41M	$-34.18M	$-33.47M	$-22.50M	$-38.99M	$-40.36M	$-38.24M	$-32.28M	$-48.36M	$-61.05M	$-37.74M	$-70.89M	$-41.63M	$115.15M	$-40.36M	$15.35M	$-58.25M	$-48.43M	$-43.16M	$-39.94M	$-51.00M	$144.35M	$-40.14M	$-41.45M	$96.53M	$-31.60M	$-35.00M	$-34.76M	$-39.34M
High Forecast	$4.95M	$4.76M	$4.47M	$4.38M	$2.94M	$5.10M	$5.28M	$-30.79M	$93.08M	$6.33M	$7.99M	$-30.19M	$-55.24M	$5.45M	$462.76M	$-32.29M	$18.42M	$-58.25M	$-48.43M	$-34.53M	$-39.94M	$-51.00M	$144.35M	$-32.11M	$-41.45M	$96.53M	$-31.60M	$-28.00M	$-34.76M	$-39.34M
Low Forecast	$-152.07M	$-146.32M	$-137.37M	$-134.53M	$-90.43M	$-156.71M	$-162.18M	$-45.19M	$-75.06M	$-194.37M	$-245.37M	$-45.28M	$-87.00M	$-167.32M	$-15.07M	$-48.43M	$12.28M	$-58.25M	$-48.43M	$-51.80M	$-39.94M	$-51.00M	$144.35M	$-48.17M	$-41.45M	$96.53M	$-31.60M	$-42.00M	$-34.76M	$-39.34M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	2.15%	-	1.91%	0.44%	0.82%	0.81%	1.08%	-0.21%	0.72%	2.77%	1.04%	0.02%	-0.56%	1.35%	0.80%	1.19%	0.60%

uniQure's average Quarter net income forecast for Mar 23 is $-40.36M, with a range of $-48.43M to $-32.29M. QURE's average Quarter net income forecast represents a -692.90% decrease compared to the company's last Quarter net income of $6.81M (Dec 22).

uniQure SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	4	4	4	4	3	3	3	5	7	3	5	4	8	4	5	4	4	3	4	3	5	4	5	4	5	5	9	6	4	4
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	$18.07M	-	$17.85M	$18.26M	$13.32M	$12.49M	$10.99M	$13.97M	$12.02M	$17.30M	$12.38M	$11.21M	$10.79M	$11.51M	$9.07M	$8.68M	$8.93M
Avg Forecast	$8.36M	$7.92M	$7.48M	$7.03M	$51.70M	$16.69M	$15.00M	$14.11M	$38.05M	$15.19M	$15.15M	$13.93M	$12.41M	$65.31M	$369.26M	$9.50M	$43.01M	$7.72M	$22.56M	$10.16M	$23.80M	$5.57M	$420.88M	$5.02M	$265.91M	$295.19M	$11.34M	$2.97M	$3.35M	$5.11M
High Forecast	$27.79M	$26.31M	$24.84M	$23.37M	$171.75M	$55.44M	$49.83M	$22.85M	$135.85M	$15.64M	$15.15M	$13.93M	$19.38M	$65.31M	$1.23B	$11.40M	$142.87M	$7.72M	$22.56M	$12.19M	$23.80M	$5.57M	$420.88M	$5.02M	$265.91M	$295.19M	$11.34M	$2.97M	$3.35M	$5.11M
Low Forecast	$1.09M	$1.03M	$972.89K	$915.25K	$6.73M	$2.17M	$1.95M	$9.07M	$2.11M	$14.74M	$15.15M	$13.93M	$2.71M	$65.31M	$48.04M	$7.60M	$5.60M	$7.72M	$22.56M	$8.13M	$23.80M	$5.57M	$420.88M	$5.02M	$265.91M	$295.19M	$11.34M	$2.97M	$3.35M	$5.11M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.28%	-	1.88%	0.42%	1.73%	0.55%	1.08%	0.59%	2.16%	0.04%	2.47%	0.04%	0.04%	1.02%	3.06%	2.59%	1.75%

uniQure's average Quarter SG&A projection for Dec 23 is $12.41M, based on 8 Wall Street analysts, with a range of $2.71M to $19.38M. The forecast indicates a -31.36% fall compared to QURE last annual SG&A of $18.07M (Sep 23).

uniQure EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	4	4	4	4	3	3	3	5	7	3	5	4	8	4	5	4	4	3	4	3	5	4	5	4	5	5	9	6	4	4
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	$-1.88	-	$-1.63	$0.15	$-1.02	$-0.84	$-1.00	$0.18	$-0.79	$8.68	$-0.91	$-0.02	$-1.21	$-0.96	$-0.63	$-1.04	$-0.58
Avg Forecast	$-0.78	$-0.75	$-0.70	$-0.69	$-0.46	$-0.80	$-0.83	$-0.78	$-0.66	$-0.99	$-1.25	$-1.28	$-1.46	$-0.85	$2.36	$-0.90	$-0.89	$-1.20	$-1.00	$-0.93	$-0.82	$-1.05	$2.97	$-0.89	$-0.85	$1.99	$-0.65	$-0.72	$-0.71	$-0.81
High Forecast	$0.10	$0.10	$0.09	$0.09	$0.06	$0.10	$0.11	$-0.63	$1.91	$0.13	$0.16	$0.17	$-1.13	$0.11	$9.50	$0.12	$0.12	$-1.20	$-1.00	$-0.93	$-0.82	$-1.05	$2.97	$-0.89	$-0.85	$1.99	$-0.65	$-0.72	$-0.71	$-0.81
Low Forecast	$-3.12	$-3.00	$-2.82	$-2.76	$-1.86	$-3.22	$-3.33	$-0.93	$-1.54	$-3.99	$-5.04	$-5.14	$-1.79	$-3.43	$-0.31	$-3.62	$-3.56	$-1.20	$-1.00	$-0.93	$-0.82	$-1.05	$2.97	$-0.89	$-0.85	$1.99	$-0.65	$-0.72	$-0.71	$-0.81
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	2.20%	-	1.81%	-0.17%	0.85%	0.84%	1.07%	-0.22%	0.75%	2.92%	1.02%	0.02%	-0.61%	1.48%	0.87%	1.45%	0.72%

According to 4 Wall Street analysts, uniQure's projected average Quarter EPS for Mar 23 is $-0.90, with a low estimate of $-3.62 and a high estimate of $0.12. This represents a -701.01% decrease compared to QURE previous annual EPS of $0.15 (Dec 22).

uniQure Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
XFOR	X4 Pharmaceuticals	$0.37	$3.67	891.89%	Buy
QURE	uniQure	$6.18	$53.67	768.45%	Buy
INZY	Inozyme Pharma	$2.88	$14.67	409.38%	Buy
STRO	Sutro Biopharma	$2.75	$11.14	305.09%	Buy
SLDB	Solid Biosciences	$5.00	$17.50	250.00%	Buy
RCKT	Rocket Pharmaceuticals	$13.66	$45.20	230.89%	Buy
LRMR	Larimar Therapeutics	$6.16	$20.33	230.03%	Buy
RGNX	REGENXBIO	$10.15	$32.00	215.27%	Buy
ABOS	Acumen Pharmaceuticals	$2.24	$7.00	212.50%	Buy
DAWN	Day One Biopharmaceuticals	$13.01	$38.80	198.23%	Buy
GPCR	Structure Therapeutics	$31.75	$92.40	191.02%	Buy
PHAT	Phathom Pharmaceuticals	$8.89	$25.83	190.55%	Buy
TERN	Terns Pharmaceuticals	$5.70	$14.25	150.00%	Buy
REPL	Replimune Group	$10.77	$24.20	124.70%	Buy
SNDX	Syndax Pharmaceuticals	$16.11	$34.30	112.91%	Buy
MRUS	Merus	$44.27	$77.13	74.23%	Buy
KNSA	Kiniksa Pharmaceuticals	$21.50	$36.33	68.98%	Buy
MGTX	MeiraGTx	$6.09	$9.00	47.78%	Buy
PCVX	Vaxcyte	$86.49	$124.00	43.37%	Buy
RNA	Avidity Biosciences	$41.35	$54.50	31.80%	Buy
AMLX	Amylyx Pharmaceuticals	$5.30	$6.67	25.85%	Buy
PTGX	Protagonist Therapeutics	$40.39	$50.00	23.79%	Buy
RYTM	Rhythm Pharmaceuticals	$58.50	$55.20	-5.64%	Buy
KRTX	Karuna Therapeutics	$329.83	$257.50	-21.93%	Buy

QURE Forecast FAQ

Is uniQure a good buy?

Yes, according to 7 Wall Street analysts, uniQure (QURE) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 6 'Buy' recommendations, accounting for 85.71% of QURE's total ratings.

What is QURE's price target?

uniQure (QURE) average price target is $53.67 with a range of $34 to $62, implying a 768.45% from its last price of $6.18. The data is based on 7 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will uniQure stock go up soon?

According to Wall Street analysts' prediction for QURE stock, the company can go up by 768.45% (from the last price of $6.18 to the average price target of $53.67), up by 903.24% based on the highest stock price target, and up by 450.16% based on the lowest stock price target.

Can uniQure stock reach $9?

QURE's average twelve months analyst stock price target of $53.67 supports the claim that uniQure can reach $9 in the near future.

What are uniQure's analysts' financial forecasts?

uniQure's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $44.02M (high $135.39M, low $8.99M), average EBITDA is $-29.855M (high $-6.1M, low $-91.824M), average net income is $-140M (high $-17.462M, low $-455M), average SG&A $97.5M (high $299.87M, low $19.92M), and average EPS is $-2.875 (high $-0.358, low $-9.329). QURE's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $13.9M (high $46.19M, low $1.81M), average EBITDA is $-9.43M (high $-1.227M, low $-31.33M), average net income is $-142M (high $18.57M, low $-570M), average SG&A $30.8M (high $102.31M, low $4.01M), and average EPS is $-2.913 (high $0.381, low $-11.706).

Did the QURE's actual financial results beat the analysts' financial forecasts?

Based on uniQure's last annual report (Dec 2023), the company's revenue was $15.84M, which missed the average analysts forecast of $232.11M by -93.17%. Apple's EBITDA was $-283M, beating the average prediction of $-174M by 62.80%. The company's net income was $-308M, beating the average estimation of $-37.736M by 717.46%. Apple's SG&A was $74.59M, missing the average forecast of $456.48M by -83.66%. Lastly, the company's EPS was $-0.0065, missing the average prediction of $-0.848 by -99.23%. In terms of the last quarterly report (Sep 2023), uniQure's revenue was $1.41M, missing the average analysts' forecast of $29.49M by -95.23%. The company's EBITDA was $-81.877M, beating the average prediction of $-20M by 309.38%. uniQure's net income was $-89.571M, beating the average estimation of $-41.632M by 115.15%. The company's SG&A was $18.07M, missing the average forecast of $65.31M by -72.33%. Lastly, the company's EPS was $-1.88, beating the average prediction of $-0.855 by 120.00%